Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis
Citations Over TimeTop 1% of 2015 papers
Abstract
Sepsis is a frequently fatal condition characterized by an uncontrolled and harmful host reaction to microbial infection. Despite the prevalence and severity of sepsis, we lack a fundamental grasp of its pathophysiology. Here we report that the cytokine interleukin-3 (IL-3) potentiates inflammation in sepsis. Using a mouse model of abdominal sepsis, we showed that innate response activator B cells produce IL-3, which induces myelopoiesis of Ly-6C(high) monocytes and neutrophils and fuels a cytokine storm. IL-3 deficiency protects mice against sepsis. In humans with sepsis, high plasma IL-3 levels are associated with high mortality even after adjusting for prognostic indicators. This study deepens our understanding of immune activation, identifies IL-3 as an orchestrator of emergency myelopoiesis, and reveals a new therapeutic target for treating sepsis.
Related Papers
- → Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation(2019)162 cited
- → Plasma Cells Are Obligate Effectors of Enhanced Myelopoiesis in Aging Bone Marrow(2019)128 cited
- → Role of colony-stimulating factor in myelopoiesis in murine long-term bone marrow cultures(1987)28 cited
- → Role of colony-stimulating factor in myelopoiesis in murine long-term bone marrow cultures(1987)2 cited
- → [Human diseases and the mechanisms regulating myelopoiesis].(2023)